Drug Type Small molecule drug |
Synonyms AGS 499, AGS499 |
Target |
Mechanism Telomerase activators(Telomerase activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization Neuromagen PharmaStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | IL | Neuromagen PharmaStartup | 27 Jun 2022 |
Cardiovascular Diseases | Preclinical | IL | Neuromagen PharmaStartup | 27 Jun 2022 |
Amyotrophic Lateral Sclerosis | Preclinical | IL | Neuromagen PharmaStartup | 03 Jan 2012 |